Agenus Stock (NASDAQ: AGEN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 810.287K |
Day Range | - - - |
52 Wk Range | 4.775 - 42.600 |
Market Cap | $214.990M |
P/E Ratio | 0.904 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 12.42% |
Days to Cover | 3.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Agenus (NASDAQ: AGEN) through any online brokerage.
Other companies in Agenus’s space includes: Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), bluebird bio (NASDAQ:BLUE), Monte Rosa Therapeutics (NASDAQ:GLUE) and Emergent BioSolutions (NYSE:EBS).
The latest price target for Agenus (NASDAQ: AGEN) was reported by HC Wainwright & Co. on Tuesday, May 7, 2024. The analyst firm set a price target for 40.00 expecting AGEN to rise to within 12 months (a possible 290.70% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Agenus (NASDAQ: AGEN) is $10.238 last updated May 10, 2024 at 5:23 PM EDT.
There are no upcoming dividends for Agenus.
Agenus’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Agenus.
Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.